Apollon Wealth Management LLC Has $757,000 Holdings in Humana Inc. (NYSE:HUM)

Apollon Wealth Management LLC raised its position in Humana Inc. (NYSE:HUM) by 6.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,983 shares of the insurance provider’s stock after purchasing an additional 168 shares during the quarter. Apollon Wealth Management LLC’s holdings in Humana were worth $757,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. International Assets Investment Management LLC raised its position in Humana by 261,025.1% in the 3rd quarter. International Assets Investment Management LLC now owns 738,984 shares of the insurance provider’s stock valued at $2,340,660,000 after buying an additional 738,701 shares during the last quarter. FMR LLC raised its holdings in shares of Humana by 23.4% in the third quarter. FMR LLC now owns 3,388,859 shares of the insurance provider’s stock valued at $1,073,387,000 after purchasing an additional 643,291 shares during the last quarter. Thrivent Financial for Lutherans lifted its position in shares of Humana by 55.6% in the third quarter. Thrivent Financial for Lutherans now owns 600,317 shares of the insurance provider’s stock worth $190,145,000 after purchasing an additional 214,535 shares in the last quarter. Retirement Systems of Alabama boosted its holdings in Humana by 735.9% during the fourth quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider’s stock worth $55,563,000 after purchasing an additional 192,801 shares during the last quarter. Finally, Pzena Investment Management LLC grew its position in Humana by 8.1% in the third quarter. Pzena Investment Management LLC now owns 2,506,250 shares of the insurance provider’s stock valued at $793,830,000 after purchasing an additional 187,903 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors.

Humana Stock Performance

Shares of NYSE HUM opened at $259.93 on Thursday. Humana Inc. has a one year low of $213.31 and a one year high of $406.46. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76. The firm has a market cap of $31.30 billion, a price-to-earnings ratio of 23.02, a P/E/G ratio of 2.11 and a beta of 0.56. The stock’s fifty day moving average price is $273.00 and its two-hundred day moving average price is $295.72.

Humana (NYSE:HUM) last released its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.18% and a return on equity of 13.20%. On average, equities analysts forecast that Humana Inc. will post 16.11 EPS for the current year.

Analysts Set New Price Targets

HUM has been the topic of several analyst reports. Truist Financial boosted their price target on shares of Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a research report on Monday, January 6th. Piper Sandler increased their price target on Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a research report on Wednesday, January 15th. Morgan Stanley decreased their price target on Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a research note on Wednesday. Royal Bank of Canada reiterated an “outperform” rating and set a $283.00 price objective on shares of Humana in a research note on Wednesday. Finally, Cantor Fitzgerald reissued a “neutral” rating and issued a $290.00 target price on shares of Humana in a research note on Wednesday. Nineteen equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, Humana currently has an average rating of “Hold” and a consensus price target of $292.26.

Insider Activity

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction dated Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the sale, the insider now directly owns 8,181 shares in the company, valued at $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.32% of the stock is owned by company insiders.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.